Articles

Original Article

The Added-value of Staging ¹⁸F-FDG PET/CT in the Prediction of Overall Survival in the Patients with Bladder Cancer

Seda Gülbahar Ateş
Bedriye Büşra Demirel
Halil Başar
Gülin Uçmak

Mol Imaging Radionucl Ther 2024; 33: 11-18 DOI: 10.4274/mirt.galenos.2023.65002 PMID:38390706

The Impact of Primary Tumor and Locoregional Metastatic Lymph Node SUV_max on Predicting Survival in Patients with Rectal Cancer

Göksel Alçın
Yasemin Şanlı
Gülçin Yeğen
Esra Kaytan Sağlam
Tevfik Fikret Çermik

Mol Imaging Radionucl Ther 2020; 29: 65-71 DOI: 10.4274/mirt.galenos.2020.40316 PMID:32368877

The Contribution of Fluorine ¹⁸F-FDG PET/CT to Lung Cancer Diagnosis, Staging and Treatment Planning

Emine Budak
Gürsel Çok
Ayşegül Akgün

Mol Imaging Radionucl Ther 2018; 27: 73-80 DOI: 10.4274/mirt.53315 PMID:29889029

The Prognostic Value of ¹⁸F-FDG PET/CT Metabolic Parameters in Predicting Treatment Response Before EGFR TKI Treatment in Patients with Advanced Lung Adenocarcinoma

Nurşin Agüloğlu
Murat Akyol
Halil Kömek
Nuran Katgı

Mol Imaging Radionucl Ther 2022; 31: 104-113 DOI: 10.4274/mirt.galenos.2022.24650 PMID:35770976

Prognostic Significance of ¹⁸F-FDG PET/CT Imaging in Survival Outcomes in Patients with Renal Cell Carcinoma

Gamze Tatar
Cihan Gündoğan
Ömer Faruk Şahin
Esra Arslan
Nurhan Ergül
Tevfik Fikret Çermik

Mol Imaging Radionucl Ther 2022; 31: 200-206 DOI: 10.4274/mirt.galenos.2022.42744 PMID:36268871

Original Research

Does Metastatic Lymph Node SUVmax Predict Survival in Patients with Esophageal Cancer?

Betül Vatankulu
Yasemin Şanlı
Esra Kaytan Sağlam
Serkan Kuyumcu
Zeynep Gözde Özkan
Ebru Yılmaz
Sevim Purisa
Işık Adalet

Mol Imaging Radionucl Ther 2015; 24: 120-127 DOI: 10.4274/mirt.36744 PMID:27529887

About Journal

Forms

Useful Links

Latest Update: 16.04.2024